← Leaderboards
Joyann Phillips Rohan
Leidos Biomedical Research, Inc.
$19,282,031
Attributed
$19,282,031
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $19.1M · FY2015–23$20M$15M$10M$5M$0
'15
'16
'17
'18
'19
'20
'21
'22
'23
Funding mix
By agency
NIH$19,282,031 · 1
By mechanism
N01$19,207,754 · 1
N02$74,277 · 1
Top collaborators
No co-investigators on record.
Most similar at Leidos Biomedical Research, Inc.
Same institution · by research overlap
- Leonard Freedman$1,216,107,431
- Leonard Freedmand$281,097,701
- Lynn Briscoe$495,968,635
- Linda Hannick$6,086,594
- Ethan Dmitrovsky$597,515,186
Others in their field
Top investigators on “Interventional Radiology”
- Mitchell D Schnall · University Of Pennsylvania$91,034,293
- Bruce J Hillman · American College Of Radiology$58,969,992
- Lynne I. Wagner · Northwestern University At Chicago$52,322,199
- Peter J O'Dwyer · University Of Pennsylvania$39,680,324
- Robert J Gray · Dana-Farber Cancer Institute$33,923,332
- Constantine A. Gatsonis · Miriam Hospital$29,189,082
Research focus
Interventional RadiologyMetabolomicsGeneticImageFutureMalignant NeoplasmsBiopsyBloodBlood SpecimenGenomicsCancer ImagingDesignDiagnosticLaboratoriesCharacteristicsEarly Therapeutic-Clinical Trials NetworkEligibility DeterminationEnrollmentClinical DataExomeClinical TrialsFine Needle Aspiration BiopsyFluorescent In Situ HybridizationMethylome
Grant awards (3)
MOLECULAR ANALYSIS OF TUMORS FOR TREATMENT SELECTION IN CLINICAL TRIALS- PHASE II$74,277
N02 · FY2023 · CA · contact PI
MOLECULAR ANALYSIS OF TUMORS FOR TREATMENT SELECTION IN CLINICAL TRIALS- PHASE II$82,243
N01 · FY2018 · CA · contact PI
MOLECULAR ANALYSIS OF TUMORS FOR TREATMENT SELECTION IN CLINICAL TRIALS- PHASE II$19,125,511
N01 · FY2015 · CA · contact PI